Rice Hall James & Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-620,408
Closed -$17.4M 302
2017
Q2
$17.4M Buy
+620,408
New +$17.2M 0.76% 62
2015
Q3
Sell
-516,132
Closed -$18.1M 316
2015
Q2
$18.1M Buy
516,132
+3,210
+0.6% +$113K 1.04% 33
2015
Q1
$18.2M Sell
512,922
-2,582
-0.5% -$87K 1.05% 28
2014
Q4
$17.9M Sell
515,504
-12,398
-2% -$437K 1.08% 26
2014
Q3
$18.6M Buy
527,902
+212,595
+67% +$8.02M 1.3% 19
2014
Q2
$12.7M Buy
315,307
+41,793
+15% +$1.6M 0.85% 48
2014
Q1
$10.9M Sell
273,514
-14,427
-5% -$519K 0.8% 48
2013
Q4
$9.51M Buy
287,941
+64,122
+29% +$2M 0.69% 48
2013
Q3
$6.57M Sell
223,819
-20,362
-8% -$639K 0.63% 48
2013
Q2
$8.23M Buy
+244,181
New +$7.56M 0.81% 47

Other funds holding DBD

Rice Hall James & Associates's DBD Position: Q3 2017 in Review

Rice Hall James & Associates sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2017, closing a stake of 620,408 shares — an estimated $17.4M sold.

Rice Hall James & Associates first reported a position in DBD in Q2 2013 and held it in 10 quarters. The position peaked at $18.6M in Q3 2014. 226 funds tracked by Wall St. Rank hold DBD as of Q3 2017.

  • Rice Hall James & Associates reported no remaining Diebold Nixdorf Incorporated position as of Q3 2017 after selling out during the quarter.
  • Rice Hall James & Associates sold 620,408 Diebold Nixdorf Incorporated shares in Q3 2017, an estimated $17.4M.
  • Rice Hall James & Associates first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 10 quarters.
  • Rice Hall James & Associates's Diebold Nixdorf Incorporated position peaked at $18.6M in Q3 2014.
  • 226 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2017.

Based on Rice Hall James & Associates's 13F filing for Q3 2017, filed 30 Oct 2017.